Ascendis Pharma AS (ASND) — Cash Flow Reinvestment Rate

Latest as of December 2025: 0.05x

Ascendis Pharma AS (ASND) has a Cash Flow Reinvestment Rate of 0.05x as of December 2025, reinvesting $3.30 Million (capex $3.30 Million ) from operating cash flow of $70.67 Million. See cash generation quality of Ascendis Pharma AS to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.05x
(Capex + Investments) / Operating CF

Total Reinvested

$3.30 Million
Capex + Investments

Operating Cash Flow

$70.67 Million
USD

Capital Expenditures

$3.30 Million
USD

Ascendis Pharma AS Cash Flow Reinvestment Rate (2013–2025)

Historical reinvestment intensity for Ascendis Pharma AS across 2 annual periods. For the full cash flow conversion analysis, see how efficiently does Ascendis Pharma AS generate cash.

Annual Cash Flow Reinvestment Rate for Ascendis Pharma AS (2013–2025)

Year-by-year capital reinvestment analysis for Ascendis Pharma AS. See financial agility of Ascendis Pharma AS to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2025 0.16x $8.15 Million $51.77 Million $8.15 Million ▼ -16.9%
2013 0.19x $1.20 Million $6.31 Million $1.20 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow